Marvell Technology, Inc.
TSX:MRV.TO · Toronto Stock Exchange
+$5.83 today
Vol 0.04M · Avg 0.09M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
282.7%
avg 14.3%
ROIC
0.0%
avg -5.7%
ROA
-24.7%
avg -6.6%
Analysis
ROE is currently the strongest return metric at 282.7% versus its period average of 14.3%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Jesse F. Ledger | Pres & Chief Executive Officer | $605,922.00 | — | — | — | — |
Katina K. Loucaides | Vice President, Corporation Sec. & Gen. Counsel | $477,119.00 | — | — | — | — |
Bernard Joseph Chiasson | Vice President of Operations & Chief Scientific Officer | $476,368.00 | — | — | — | — |
Luigi Berardelli | Vice President of Sales & Marketing | $416,640.00 | — | — | — | — |
Mary-Jane E. Burkett | Vice President & Chief Financial Officer | $364,057.00 | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +16.0% | +48.5% (19yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Recent growth has been strongest in Revenue at +16.0% over three years. Forward estimates point to Revenue at +48.5% (19yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Vinergy Capital Inc.
VIN.CN
$20.18M
Ayr Wellness Inc.
AYR-A.CN
$18.10M
IM Cannabis Corp.
IMCC.CN
$17.17M
Numinus Wellness Inc.
NUMI.TO
$16.03M
Antibe Therapeutics Inc.
ATE.TO
$15.64M
EXMceuticals Inc.
EXM.CN
$15.15M
LexaGene Holdings Inc.
LXG.V
$14.77M
Chalice Brands Ltd.
CHAL.CN
$14.70M
RIV Capital Inc.
RIV.CN
$13.70M
Orion Nutraceuticals Inc.
ORI.CN
$11.72M
Who manages MRV.TO?
Marvell Technology, Inc. (MRV.TO) lists 5 active executives. The top listed executive is Jesse F. Ledger, Pres & Chief Executive Officer.
Explore More
Continue the stock analysis
Jump to another research area for this company.